<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="658">
  <stage>Registered</stage>
  <submitdate>29/08/2005</submitdate>
  <approvaldate>29/08/2005</approvaldate>
  <nctid>NCT00138788</nctid>
  <trial_identification>
    <studytitle>Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases</studytitle>
    <scientifictitle>To Determine Which of Two Radiotherapy Brain Fractionation Schemes is Superior in the Treatment of Brain Metastases</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>95/29 Graham</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Neoplasm Metastasis</healthcondition>
    <healthcondition>Brain Neoplasms</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Other cancer types</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Brain</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Radiotherapy, dose fractionation

Treatment: surgery: Radiotherapy, dose fractionation


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Progression free survival</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cost effectiveness</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Toxicity</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Neurological functioning</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Survival</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  ECOG performance status 0 - 2.

          -  Brain metastasis. Brain biopsy not obligatory if known previous malignancy and
             multiple lesions typical on computed tomography (CT) scan of brain. Solitary lesions,
             if suitably located, should be biopsied and preferably excised.

          -  Extracranial disease stable or absent (i.e. no progression over 2 months) OR
             concurrent presentation of brain metastasis and extracranial disease at time of
             initial cancer diagnosis.

          -  Able to consent

          -  Life expectancy exceeds 2 months</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/1996</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>112</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/03/2007</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Cancer Care Centre, St George Hospital - Sydney</hospital>
    <postcode>2217 - Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>St George Hospital, Australia</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a comparison of radiotherapy fractionation schemes for brain metastasis.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00138788</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor Peter H Graham</name>
      <address>Cancer Care Centre, St George Hospital, Sydney, Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>